- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05552014
Study on the Efficacy Mechanism of Natural Psychotherapy for Neurosis
September 21, 2022 updated by: Xiang Yang Zhang, Beijing HuiLongGuan Hospital
Research on the Efficacy Mechanism of Natural Psychotherapy for Neurosis
We explore objective indicators of the efficacy of natural psychotherapy in the treatment of disorders such as obsessive-compulsive disorder
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xiang Y Zhang, M.D., Ph.D
- Phone Number: +86-10-62710644
- Email: zhangxy@psych.ac.cn
Study Locations
-
-
-
Beijing, China, 100096
- Recruiting
- Institute of Psychology, Chinese Academy of Sciences
-
Contact:
- Xiang Y Zhang, M.D.,Ph.D
- Phone Number: 6299 +86-10-62715511
- Email: zhangxy@psych.ac.cn
-
Principal Investigator:
- Xiang Y Zhang, M.D.,Ph.D
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 50 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Have a diagnosis of obsessive-compulsive disorder or compulsive behavior
- Duration of symptoms for not less than 12 months
- Age 15-50 years old.
- You can participate in the whole experiment and offline assessment in Beijing
Exclusion Criteria:
- Documented disease of physical diseases including, but not limited to stroke, tumor, Parkinson's disease, Huntington's disease, seizure, epilepsy, history of brain trauma
- Subjects who suffered from alcohol or illegal drug abuse/dependence
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Natural Psychotherapy
Intervention using natural psychotherapy for OCD patients for two to three hours once a week for eight weeks
|
Natural psychotherapy is based on "Morita therapy" and is a psychotherapy that fully reflects the characteristics of Chinese culture, taking into account the Chinese cultural background and actual clinical characteristics.
|
Placebo Comparator: Mental Health Education
Mental health education was given to another group of OCD patients for two hours once a week for eight weeks
|
Mental Health Education Seminar
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical symptoms
Time Frame: 12 weeks
|
Obsessive-compulsive symptoms were assessed according to the Obsessive-Compulsive Scale
|
12 weeks
|
Cognitive function
Time Frame: 12 weeks
|
Cognitive function as assessed by RBANS
|
12 weeks
|
Prospective memory
Time Frame: 12 weeks
|
Whether the patient's prospective memory is effectively improved using EEG and NMR
|
12 weeks
|
Mood and behavior
Time Frame: 12 weeks
|
Mood changes judged using gait and face recognition
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Xiang Y Zhang, M.D, Ph.D, Institute of Psychology, Chinese Academy of Science
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2022
Primary Completion (Anticipated)
December 1, 2023
Study Completion (Anticipated)
June 1, 2024
Study Registration Dates
First Submitted
September 21, 2022
First Submitted That Met QC Criteria
September 21, 2022
First Posted (Actual)
September 23, 2022
Study Record Updates
Last Update Posted (Actual)
September 23, 2022
Last Update Submitted That Met QC Criteria
September 21, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CASPsy5
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
Data with be available on request
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obsessive-Compulsive Disorder
-
Anne Katrine PagsbergCopenhagen Trial Unit, Center for Clinical Intervention Research; Danish Research...Active, not recruitingObsessive-Compulsive Disorder in Children | Obsessive-Compulsive Disorder in AdolescenceDenmark
-
Baylor College of MedicineRecruitingObsessive-Compulsive Disorder | Cognitive Behavioral Therapy | Obsessive-Compulsive Disorder in Children | Obsessive-Compulsive Disorder in AdolescenceUnited States
-
Chaim HuijserLevvelRecruitingObsessive-Compulsive Disorder | Anxiety Disorders and Symptoms | Obsessive-Compulsive Disorder in Children | Obsessive-Compulsive Disorder in AdolescenceNetherlands
-
Stanford UniversityCompletedObsessive Compulsive DisorderUnited States
-
NYU Langone HealthCompletedObsessive Compulsive DisorderUnited States
-
Massachusetts General HospitalActive, not recruitingObsessive Compulsive DisorderUnited States
-
Boston University Charles River CampusCompletedObsessive Compulsive DisorderUnited States
-
Butler HospitalNational Institute of Mental Health (NIMH)CompletedObsessive Compulsive DisorderUnited States
-
Karolinska InstitutetCompletedObsessive Compulsive DisorderSweden
-
Roseli ShavittCompleted
Clinical Trials on Natural Psychotherapy
-
Universidade Federal do Rio de JaneiroCompleted
-
Sprim Advanced Life SciencesArtsana S.p.a.CompletedFeeding Behavior
-
Randi UlbergUniversity of OsloCompleted
-
Hopital MontfortThe Ottawa HospitalCompletedDepression | Parkinson's DiseaseCanada
-
Marianne Lau, MD, DSci.The Ministry of Science, Technology and Innovation, DenmarkUnknownBulimia Nervosa (BN) | Binge Eating Disorder (BED) | Eating Disorder Not Otherwise Specified (EDNOS)Denmark
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Completed
-
University Hospital FreiburgCompletedChronic Major Depressive DisorderGermany
-
Oslo University HospitalSouth-Eastern Norway Regional Health AuthorityUnknown
-
Memorial Sloan Kettering Cancer CenterUniversity of Manitoba; National Cancer Institute (NCI); Visiting Nurse Service... and other collaboratorsCompleted
-
Centre Hospitalier Régional Metz-ThionvilleCentral Hospital, Nancy, France; University of LorraineCompletedBreast Cancer FemaleFrance